Cardiomyopathy clinical trials at UCSD
2 research studies open to new patients
open to eligible people ages 8-60
The goal is to determine how lifestyle and exercise impact the well-being of individuals with hypertrophic cardiomyopathy (HCM) and long QT syndrome (LQTS).
San Diego, California and other locations
open to eligible people ages 18 years and up
Open label study to evaluate tafamidis for the treatment of transthyretin cardiomyopathy
La Jolla, California and other locations